14.07.2017 - The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)